free hit counters
Brazilian Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 41 - 60 out of 84 displayed.
«  1  2 3  4  5 »

The European Commission approves the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings

Read more ››
By: GlobeNewswire - 06 Dec 2024

Former CSL CEO Paul Perreault appointed strategic adviser to Microbio

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2024

Biogénesis Bagó opens offices in Vietnam, strengthening its presence in Asia

Read more ››
By: PR Newswire Association LLC. - 03 Dec 2024
Related companies:  BIOGÉNESIS BAGÓ HEALTH ANIMAL LTDA. | Biogenesis Bago SA

Novo Nordisk to present new data from sickle cell disease and haemophilia trials at the 66th American Society of Hematology (ASH) annual meeting

Read more ››
By: GlobeNewswire - 03 Dec 2024

Pfizer Receives Authorization from Health Authority for Its 20-valent Pneumococcal Conjugate Vaccine for Infants and Children

Read more ››
By: PR Newswire Association LLC. - 03 Dec 2024

Novo Nordisk A/S - share repurchase programme

Read more ››
By: GlobeNewswire - 02 Dec 2024

United Health Products Provides Update on Clinical Study Process

Read more ››
By: GlobeNewswire - 02 Dec 2024

Microbio Appoints Paul Brennan as Chair of the Board

Read more ››
By: PR Newswire Association LLC. - 28 Nov 2024

Mangosteen Marvel MangoSoothe Outperforms Leading Joint Health Supplements

Read more ››
By: GlobeNewswire - 28 Nov 2024
Related companies:  NAIAD Drug Design | Naiad Lab Inc.

Novo Nordisk A/S - share repurchase programme

Read more ››
By: GlobeNewswire - 25 Nov 2024

Novo AI's Solution Boosts APRIL International's Efficiency by 400%

Read more ››
By: PR Newswire Association LLC. - 25 Nov 2024

Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking

Read more ››
By: GlobeNewswire - 19 Nov 2024

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››
By: GlobeNewswire - 19 Nov 2024

Novo Nordisk A/S - share repurchase programme

Read more ››
By: GlobeNewswire - 18 Nov 2024

CHMP recommends RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer

Read more ››
By: GlobeNewswire - 15 Nov 2024

Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren’s disease study

Read more ››
By: GlobeNewswire - 14 Nov 2024

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››
By: GlobeNewswire - 13 Nov 2024

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››
By: GlobeNewswire - 12 Nov 2024

Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes

Read more ››
By: GlobeNewswire - 12 Nov 2024

Novo Nordisk A/S purchases B shares worth DKK 4,736 million from Novo Holdings A/S under the 2024 share repurchase programme

Read more ››
By: GlobeNewswire - 08 Nov 2024
«  1  2 3  4  5 »

Looking for companies outside of Brazil?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • April 2025
    • Barcelona: RESI Europe 2025
    • London: BioTrinity 2025
    • Pharma-Biotech Product & Company Valuation Workshop
See Events »
Add an Event »

Latest company news

RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) demonstrates significant overall survival benefit in patients with EGFR-mutated advanced non-small cell lung cancer versus osimertinib
26 Mar 2025 (GlobeNewswire)

The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
24 Mar 2025 (GlobeNewswire)

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial
10 Mar 2025 (GlobeNewswire)

Biotechgate database

About Biotechgate
The Brazilian Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com